Evaluation of the effectiveness and impact of Nirsevimab in Galicia

The purpose of NIRSE-GAL is to evaluate the impact of the inclusion of nirsevimab in the Galician immunisation schedule on the prevention of Respiratory Syncytial Respiratory Syncytial Virus (RSV) infections in children. The NIRSE-GAL study shows in real time the evolution of the coverage achieved by immunisation with Nirsevimab in children and compares RSV admissions in different population groups of children and adults in Galicia in Spain with previous years. In addition, NIRSE-GAL will evaluate the impact of Nirsevimab on the use of primary care and emergency resources, as well as on short- and medium-term morbidity.